US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist
  • 18.770
  • -1.020-5.15%
Trading Nov 29 11:04 ET
27.44MMarket Cap-1145P/E (TTM)

Forte Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-15.53%8.63M
41.89%12.82M
13.84%7.8M
133.78%32.49M
29.20%6.38M
198.45%10.22M
199.14%9.03M
172.67%6.86M
-35.33%13.9M
49.71%4.94M
Selling and administrative expenses
-28.28%2.76M
273.51%7.08M
66.88%3.45M
27.97%10.62M
14.81%2.81M
88.21%3.85M
-4.58%1.9M
13.56%2.07M
8.76%8.3M
25.89%2.45M
-General and administrative expense
-28.28%2.76M
273.51%7.08M
66.88%3.45M
27.97%10.62M
14.81%2.81M
88.21%3.85M
-4.58%1.9M
13.56%2.07M
8.76%8.3M
25.89%2.45M
Research and development costs
-7.83%5.87M
-19.60%5.74M
-9.07%4.35M
290.81%21.86M
43.37%3.57M
361.86%6.37M
590.43%7.14M
590.76%4.79M
-59.62%5.59M
84.02%2.49M
Operating profit
15.53%-8.63M
-41.89%-12.82M
-13.84%-7.8M
-133.78%-32.49M
-29.20%-6.38M
-198.45%-10.22M
-199.14%-9.03M
-172.67%-6.86M
35.33%-13.9M
-49.71%-4.94M
Net non-operating interest income expense
593.83%1.12M
162K
Non-operating interest income
----
----
----
593.83%1.12M
----
----
----
----
--162K
----
Other net income (expense)
-9.20%237K
122.46%307K
276.47%384K
21.38%-114K
-515.00%-615K
1,034.78%261K
1,020.00%138K
292.45%102K
34.68%-145K
-138.10%-100K
Other non- operating income (expenses)
-9.20%237K
122.46%307K
276.47%384K
21.38%-114K
-515.00%-615K
1,034.78%261K
1,020.00%138K
292.45%102K
34.68%-145K
-138.10%-100K
Income before tax
15.70%-8.39M
-40.64%-12.51M
-9.88%-7.42M
-126.79%-31.48M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.9M
-163.07%-6.75M
36.07%-13.88M
-45.97%-4.88M
Income tax
Net income
15.70%-8.39M
-40.64%-12.51M
-9.88%-7.42M
-126.79%-31.48M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.9M
-163.07%-6.75M
36.07%-13.88M
-45.97%-4.88M
Net income continuous Operations
15.70%-8.39M
-40.64%-12.51M
-9.88%-7.42M
-126.79%-31.48M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.9M
-163.07%-6.75M
36.07%-13.88M
-45.97%-4.88M
Minority interest income
Net income attributable to the parent company
15.70%-8.39M
-40.64%-12.51M
-9.88%-7.42M
-126.79%-31.48M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.9M
-163.07%-6.75M
36.07%-13.88M
-45.97%-4.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.70%-8.39M
-40.64%-12.51M
-9.88%-7.42M
-126.79%-31.48M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.9M
-163.07%-6.75M
36.07%-13.88M
-45.97%-4.88M
Basic earnings per share
30.90%-4.54
35.71%-6.75
50.00%-4
-25.00%-25
82.83%-1.03
-46.00%-6.57
-100.00%-10.5
-88.24%-8
48.39%-20
-14.29%-6
Diluted earnings per share
30.90%-4.54
35.71%-6.75
50.00%-4
-25.00%-25
82.83%-1.03
-46.00%-6.57
-100.00%-10.5
-88.24%-8
48.39%-20
-14.29%-6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -15.53%8.63M41.89%12.82M13.84%7.8M133.78%32.49M29.20%6.38M198.45%10.22M199.14%9.03M172.67%6.86M-35.33%13.9M49.71%4.94M
Selling and administrative expenses -28.28%2.76M273.51%7.08M66.88%3.45M27.97%10.62M14.81%2.81M88.21%3.85M-4.58%1.9M13.56%2.07M8.76%8.3M25.89%2.45M
-General and administrative expense -28.28%2.76M273.51%7.08M66.88%3.45M27.97%10.62M14.81%2.81M88.21%3.85M-4.58%1.9M13.56%2.07M8.76%8.3M25.89%2.45M
Research and development costs -7.83%5.87M-19.60%5.74M-9.07%4.35M290.81%21.86M43.37%3.57M361.86%6.37M590.43%7.14M590.76%4.79M-59.62%5.59M84.02%2.49M
Operating profit 15.53%-8.63M-41.89%-12.82M-13.84%-7.8M-133.78%-32.49M-29.20%-6.38M-198.45%-10.22M-199.14%-9.03M-172.67%-6.86M35.33%-13.9M-49.71%-4.94M
Net non-operating interest income expense 593.83%1.12M162K
Non-operating interest income ------------593.83%1.12M------------------162K----
Other net income (expense) -9.20%237K122.46%307K276.47%384K21.38%-114K-515.00%-615K1,034.78%261K1,020.00%138K292.45%102K34.68%-145K-138.10%-100K
Other non- operating income (expenses) -9.20%237K122.46%307K276.47%384K21.38%-114K-515.00%-615K1,034.78%261K1,020.00%138K292.45%102K34.68%-145K-138.10%-100K
Income before tax 15.70%-8.39M-40.64%-12.51M-9.88%-7.42M-126.79%-31.48M-20.40%-5.87M-192.79%-9.96M-193.11%-8.9M-163.07%-6.75M36.07%-13.88M-45.97%-4.88M
Income tax
Net income 15.70%-8.39M-40.64%-12.51M-9.88%-7.42M-126.79%-31.48M-20.40%-5.87M-192.79%-9.96M-193.11%-8.9M-163.07%-6.75M36.07%-13.88M-45.97%-4.88M
Net income continuous Operations 15.70%-8.39M-40.64%-12.51M-9.88%-7.42M-126.79%-31.48M-20.40%-5.87M-192.79%-9.96M-193.11%-8.9M-163.07%-6.75M36.07%-13.88M-45.97%-4.88M
Minority interest income
Net income attributable to the parent company 15.70%-8.39M-40.64%-12.51M-9.88%-7.42M-126.79%-31.48M-20.40%-5.87M-192.79%-9.96M-193.11%-8.9M-163.07%-6.75M36.07%-13.88M-45.97%-4.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.70%-8.39M-40.64%-12.51M-9.88%-7.42M-126.79%-31.48M-20.40%-5.87M-192.79%-9.96M-193.11%-8.9M-163.07%-6.75M36.07%-13.88M-45.97%-4.88M
Basic earnings per share 30.90%-4.5435.71%-6.7550.00%-4-25.00%-2582.83%-1.03-46.00%-6.57-100.00%-10.5-88.24%-848.39%-20-14.29%-6
Diluted earnings per share 30.90%-4.5435.71%-6.7550.00%-4-25.00%-2582.83%-1.03-46.00%-6.57-100.00%-10.5-88.24%-848.39%-20-14.29%-6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-6.35%